| KRYS Stock | | | USD 190.40 8.11 4.45% |
Krystal Biotech financial indicator trend analysis is infinitely more than just investigating Krystal Biotech recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Krystal Biotech is a good investment. Please check the relationship between Krystal Biotech Ebitda and its Ebit accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krystal Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in manufacturing.
For more information on how to buy Krystal Stock please use our
How to Invest in Krystal Biotech guide.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Krystal Biotech Ebitda account and
Ebit. At this time, the significance of the direction appears to have totally related.
The correlation between Krystal Biotech's Ebitda and Ebit is 1.0. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Ebit in the same time period over historical financial statements of Krystal Biotech, assuming nothing else is changed. The correlation between historical values of Krystal Biotech's Ebitda and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Krystal Biotech are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Ebitda i.e., Krystal Biotech's Ebitda and Ebit go up and down completely randomly.
Correlation Coefficient | 1.0 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Most indicators from Krystal Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Krystal Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krystal Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in manufacturing.
For more information on how to buy Krystal Stock please use our
How to Invest in Krystal Biotech guide.At this time, Krystal Biotech's
Selling General Administrative is comparatively stable compared to the past year.
Tax Provision is likely to gain to about 2.1
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 164
M in 2024.
When running Krystal Biotech's price analysis, check to
measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to
predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.